Ribavirin for chronic hepatitis E virus infection in transplant recipients.

MLA

Kamar, Nassim, et al. “Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients.” The New England Journal of Medicine, vol. 370, no. 12, Mar. 2014, pp. 1111–20. EBSCOhost, https://doi.org/10.1056/NEJMoa1215246.

APA

Kamar, N., Izopet, J., Tripon, S., Bismuth, M., Hillaire, S., Dumortier, J., Radenne, S., Coilly, A., Garrigue, V., D’Alteroche, L., Buchler, M., Couzi, L., Lebray, P., Dharancy, S., Minello, A., Hourmant, M., Roque-Afonso, A.-M., Abravanel, F., Pol, S., … Mallet, V. (2014). Ribavirin for chronic hepatitis E virus infection in transplant recipients. The New England Journal of Medicine, 370(12), 1111–1120. https://doi.org/10.1056/NEJMoa1215246

Chicago

Kamar, Nassim, Jacques Izopet, Simona Tripon, Michael Bismuth, Sophie Hillaire, Jérôme Dumortier, Sylvie Radenne, et al. 2014. “Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients.” The New England Journal of Medicine 370 (12): 1111–20. doi:10.1056/NEJMoa1215246.